PMGC Holdings Q2 Revenue Nearly Doubles Sequentially; Assets Hit $36.6M
ELAB is trading near its 52-week low of $0.84 (11% above the low) on light trading volume (0.1× avg).
Summary
PMGC Holdings reported Q2 2026 revenue of $1.31 million, up 92% sequentially from $682K in Q1 and versus nil a year ago. Total assets reached $36.6 million, up 184% from year-end 2025, with cash at $18.1 million — the largest in company history. The A&B Aerospace acquisition closed May 11 and contributed partial-period revenue; the company now has five operating subsidiaries. This follows a series of positive developments including patent licenses and Phase III drug results, but the going concern warning from the last 10-Q remains a key risk. The balance sheet growth is material for a micro-cap, though revenue remains modest in absolute terms.
At the time of this announcement, ELAB was trading at $0.93 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $0.84 to $309.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.